Is there a role for bowel rest in nutrition management of crohn's disease?

Nutrition in Clinical Practice

Volumn 23, Issue 3, 2008, Pages 309-317

  Wiese, Dawn M ^a,b   Rivera, Rene ^b   Seidner, Douglas L ^c  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c Vanderbilt Center for Human Nutrition   (United States)

Author keywords

Crohn's disease; Enteral nutrition; Inflammatory bowel diseases; Nutrition; Nutrition therapy; Parenteral nutrition

Indexed keywords

ADALIMUMAB; ANTIOXIDANT; ARGININE; CANCER GROWTH FACTOR; CORTICOSTEROID; FISH OIL; INFLIXIMAB; INTERLEUKIN 1; INTERLEUKIN 6; LONG CHAIN TRIACYLGLYCEROL; MEDIUM CHAIN TRIACYLGLYCEROL; MONOUNSATURATED FATTY ACID; NITROGEN; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PLACEBO; PREDNISOLONE; PREDNISONE; RNA; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA;

BODY WEIGHT; CALORIC INTAKE; CORTICOSTEROID THERAPY; CROHN DISEASE; DIET RESTRICTION; DIET SUPPLEMENTATION; DIET THERAPY; DISEASE ACTIVITY; DRUG FATALITY; DRUG MEGADOSE; ELEMENTAL DIET; ENTERIC FEEDING; FOLLOW UP; HUMAN; INFECTION; LIPID COMPOSITION; LOW DRUG DOSE; MALIGNANT NEOPLASTIC DISEASE; NASOGASTRIC TUBE; NONHUMAN; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION; PRACTICE GUIDELINE; PROTEIN INTAKE; REMISSION; REVIEW; TREATMENT OUTCOME; ULCERATIVE COLITIS; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL;

CROHN DISEASE; ENTERAL NUTRITION; FOOD, FORMULATED; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REMISSION INDUCTION;

EID: 53449101824     PISSN: 08845336     EISSN: None     Source Type: Journal    
DOI: 10.1177/0884533608318674     Document Type: Review

References (69)

1. Greenberg GR, Fleming CR, Jeejeebhoy KN, Rosenberg IH, Sales D., Tremaine WJ Controlled trial of bowel rest and nutritional support in the management of Crohn's disease. Gut. 1988 ; 29 (10). 1309-1315. (Pubitemid 18250778)
2. Gee MI, Grace MG, Wensel RH, Sherbaniuk R., Thomson AB Protein-energy malnutrition in gastroenterology outpatients: increased risk in Crohn's disease. J Am Diet Assoc. 1985 ; 85 (11). 1466-1474. (Pubitemid 16235220)
3. Geerling BJ, Badart-Smook A., Stockbrugger RW, Brummer RJ Comprehensive nutritional status in patients with long-standing Crohn disease currently in remission. Am J Clin Nutr. 1998 ; 67 (5). 919-926. (Pubitemid 28196667)
4. Lanfranchi GA, Brignola C., Campieri M., et al. Assessment of nutritional status in Crohn's disease in remission or low activity. Hepatogastroenterology. 1984 ; 31 (3). 129-132. (Pubitemid 14096934)
5. Summers RW, Switz DM, Sessions JT Jr, et al. National Cooperative Crohn's Disease Study: results of drug treatment. Gastroenterology. 1979 ; 77 (4, pt 2). 847-869. (Pubitemid 9242048)
6. Dudrick SJ, Ruberg RL Principles and practice of parenteral nutrition. Gastroenterology. 1971 ; 61 (6). 901-910.
7. Gouma DJ, von Meyenfeldt MF, Rouflart M., Soeters PB Preoperative total parenteral nutrition (TPN) in severe Crohn's disease. Surgery. 1988 ; 103 (6). 648-652. (Pubitemid 18154984)
8. Fischer JE, Foster GS, Abel RM, Abbott WM, Ryan JA Hyperalimentation as primary therapy for inflammatory bowel disease. Am J Surg. 1973 ; 125 (2). 165-175.
9. Muller JM, Keller HW, Erasmi H., Pichlmaier H. Total parenteral nutrition as the sole therapy in Crohn's disease: a prospective study. Br J Surg. 1983 ; 70 (1). 40-43. (Pubitemid 13176029)
10. Rhodes J., Rose J. Does food affect acute inflammatory bowel disease? The role of parenteral nutrition, elemental and exclusion diets. Gut. 1986 ; 27 (5). 471-474. (Pubitemid 16079744)
11. Harries AD, Danis VA, Heatley RV Influence of nutritional status on immune functions in patients with Crohn's disease. Gut. 1984 ; 25 (5). 465-472. (Pubitemid 14144018)
12. Leijonmarck CE, Bergstrand LO, Carlstedt-Duke B., et al. Total parenteral nutrition and the function of the intestinal microflora in Crohn's disease. Scand J Gastroenterol. 1988 ; 23 (1). 59-64. (Pubitemid 18067028)
13. Ostro MJ, Greenberg GR, Jeejeebhoy KN Total parenteral nutrition and complete bowel rest in the management of Crohn's disease. JPEN J Parenter Enteral Nutr. 1985 ; 9 (3). 280-287. (Pubitemid 15032925)
14. Elson CO, Layden TJ, Nemchausky BA, Rosenberg JL, Rosenberg IH An evaluation of total parenteral nutrition in the management of inflammatory bowel disease. Dig Dis Sci. 1980 ; 25 (1). 42-48. (Pubitemid 10132428)
15. Lerebours E., Messing B., Chevalier B., Bories C., Colin R., Bernier JJ An evaluation of total parenteral nutrition in the management of steroid-dependent and steroid-resistant patients with Crohn's disease. JPEN J Parenter Enteral Nutr. 1986 ; 10 (3). 274-278. (Pubitemid 16063387)
16. Dickinson RJ, Ashton MG, Axon AT, Smith RC, Yeung CK, Hill GL Controlled trial of intravenous hyperalimentation and total bowel rest as an adjunct to the routine therapy of acute colitis. Gastroenterology. 1980 ; 79 (6). 1199-1204. (Pubitemid 11250460)
17. Reilly J., Ryan JA, Strole W., Fischer JE Hyperalimentation in inflammatory bowel disease. Am J Surg. 1976 ; 131 (2). 192-200.
18. O'Morain C., Segal AM, Levi AJ, Valman HB Elemental diet in acute Crohn's disease. Arch Dis Child. 1983 ; 58 (1). 44-47.
19. O'Morain C., Segal AW, Levi AJ Elemental diets in treatment of acute Crohn's disease. BMJ. 1980 ; 281 (6249). 1173-1175. (Pubitemid 10024696)
20. O'Morain C., Segal AW, Levi AJ Elemental diet as primary treatment of acute Crohn's disease: a controlled trial. Br Med J (Clin Res Ed). 1984 ; 288 (6434). 1859-1862.
21. Saverymuttu S., Hodgson HJ, Chadwick VS Controlled trial comparing prednisolone with an elemental diet plus non-absorbable antibiotics in active Crohn's disease. Gut. 1985 ; 26 (10). 994-998. (Pubitemid 16238074)
22. Bos LP, Weterman IT Total parenteral nutrition in Crohn's disease. World J Surg. 1980 ; 4 (2). 163-165.
23. Lochs H., Meryn S., Marosi L., Ferenci P., Hortnagl H. Has total bowel rest a beneficial effect in the treatment of Crohn's disease ? Clin Nutr. 1983 ; 2 (1). 61-64. (Pubitemid 14214907)
24. Gassull MA, Abad A., Cabre E., Gonzalez-Huix F., Gine JJ, Dolz C. Enteral nutrition in inflammatory bowel disease. Gut. 1986 ; 27 (suppl 1). 76-80. (Pubitemid 17187787)
25. A.S.P.E.N. Board of Directors. Guidelines for use of total parenteral nutrition in the hospitalized adult patient. JPEN J Parenter Enteral Nutr. 1986 ; 10 (5). 441-445.
26. A.S.P.E.N. Board of Directors. Guidelines for the use of enteral nutrition in the adult patient. JPEN J Parenter Enteral Nutr. 1987 ; 11 (5). 435-439.
27. American Society for Parenteral and Enteral Nutrition. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr. 1993 ; 17 (4 )(suppl). 1SA - 52SA.
28. A.S.P.E.N. Board of Directors and the Clinical Guidelines Task Force. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients [published correction appears in JPEN J Parenter Enteral Nutr. 2002 ; 26 (2). 144 ]. JPEN J Parenter Enteral Nutr. 2002 ; 26 (1 )(suppl). 1SA - 138SA.
29. Cravo M., Camilo ME, Correia JP Nutritional support in Crohn's disease: which route ? Am J Gastroenterol. 1991 ; 86 (3). 317-321.
30. Koretz RL, Lipman TO, Klein S. AGA technical review on parenteral nutrition. Gastroenterology. 2001 ; 121 (4). 970-1001. (Pubitemid 32959408)
31. Koretz RL, Avenell A., Lipman TO, Braunschweig CL, Milne AC Does enteral nutrition affect clinical outcome? A systematic review of the randomized trials. Am J Gastroenterol. 2007 ; 102 (2). 412-429, 468. (Pubitemid 46160556)
32. Rigaud D., Cosnes J., Le Quintrec Y., Rene E., Gendre JP, Mignon M. Controlled trial comparing two types of enteral nutrition in treatment of active Crohn's disease: elemental versus polymeric diet. Gut. 1991 ; 32 (12). 1492-1497.
33. Giaffer MH, North G., Holdsworth CD Controlled trial of polymeric versus elemental diet in treatment of active Crohn's disease. Lancet. 1990 ; 335 (8693). 816-819. (Pubitemid 20113734)
34. Verma S., Brown S., Kirkwood B., Giaffer MH Polymeric versus elemental diet as primary treatment in active Crohn's disease: a randomized, double-blind trial. Am J Gastroenterol. 2000 ; 95 (3). 735-739. (Pubitemid 30123912)
35. Akobeng AK, Miller V., Stanton J., Elbadri AM, Thomas AG Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn's disease. J Pediatr Gastroenterol Nutr. 2000 ; 30 (1). 78-84. (Pubitemid 30349950)
36. Zachos M., Tondeur M., Griffiths AM Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database Syst Rev. 2007 ;(1). CD000542.
37. Gassull MA, Fernandez-Banares F., Cabre E., et al. Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial. Gut. 2002 ; 51 (2). 164-168. (Pubitemid 34791440)
38. Middleton SJ, Rucker JT, Kirby GA, Riordan AM, Hunter JO Long-chain triglycerides reduce the efficacy of enteral feeds in patients with active Crohn's disease. Clin Nutr. 1995 ; 14 (4). 229-236.
39. Leiper K., Woolner J., Mullan MM, et al. A randomised controlled trial of high versus low long chain triglyceride whole protein feed in active Crohn's disease. Gut. 2001 ; 49 (6). 790-794. (Pubitemid 33096036)
40. de Jong NS, Leach ST, Day AS Polymeric formula has direct anti-inflammatory effects on enterocytes in an in vitro model of intestinal inflammation. Dig Dis Sci. 2007 ; 52 (9). 2029-2036. (Pubitemid 47246499)
41. Meister D., Bode J., Shand A., Ghosh S. Anti-inflammatory effects of enteral diet components on Crohn's disease-affected tissues in vitro. Dig Liver Dis. 2002 ; 34 (6). 430-438. (Pubitemid 34679066)
42. Breese EJ, Michie CA, Nicholls SW, et al. The effect of treatment on lymphokine-secreting cells in the intestinal mucosa of children with Crohn's disease. Aliment Pharmacol Ther. 1995 ; 9 (5). 547-552.
43. Yamamoto T., Nakahigashi M., Saniabadi AR, et al. Impacts of long-term enteral nutrition on clinical and endoscopic disease activities and mucosal cytokines during remission in patients with Crohn's disease: a prospective study. Inflamm Bowel Dis. 2007 ; 13 (12). 1493-1501.
44. Yamamoto T., Nakahigashi M., Umegae S., Kitagawa T., Matsumoto K. Impact of elemental diet on mucosal inflammation in patients with active Crohn's disease: cytokine production and endoscopic and histological findings. Inflamm Bowel Dis. 2005 ; 11 (6). 580-588. (Pubitemid 40826346)
45. Calder PC n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr. 2006 ; 83 (6 )(suppl). 1505S - 1519S. (Pubitemid 44713092)
46. Vilaseca J., Salas A., Guarner F., Rodriguez R., Martinez M., Malagelada JR Dietary fish oil reduces progression of chronic inflammatory lesions in a rat model of granulomatous colitis. Gut. 1990 ; 31 (5). 539-544. (Pubitemid 20185956)
47. Shoda R., Matsueda K., Yamato S., Umeda N. Therapeutic efficacy of n-3 polyunsaturated fatty acid in experimental Crohn's disease. J Gastroenterol. 1995 ; 30 (suppl 8). 98-101.
48. Seidner DL, Lashner BA, Brzezinski A., et al. An oral supplement enriched with fish oil, soluble fiber, and antioxidants for corticosteroid sparing in ulcerative colitis: a randomized, controlled trial. Clin Gastroenterol Hepatol. 2005 ; 3 (4). 358-369. (Pubitemid 40488344)
49. Belluzzi A., Brignola C., Campieri M., Pera A., Boschi S., Miglioli M. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med. 1996 ; 334 (24). 1557-1560. (Pubitemid 26177482)
50. Belluzzi A., Boschi S., Brignola C., Munarini A., Cariani G., Miglio F. Polyunsaturated fatty acids and inflammatory bowel disease. Am J Clin Nutr. 2000 ; 71 (1 )(suppl). 339S - 342S. (Pubitemid 30046138)
51. Braga M., Gianotti L., Nespoli L., Radaelli G., Di Carlo V. Nutritional approach in malnourished surgical patients: a prospective randomized study. Arch Surg. 2002 ; 137 (2). 174-180. (Pubitemid 34142134)
52. Gianotti L., Braga M., Fortis C., et al. A prospective, randomized clinical trial on perioperative feeding with an arginine-, omega-3 fatty acid-, and RNA-enriched enteral diet: effect on host response and nutritional status. JPEN J Parenter Enteral Nutr. 1999 ; 23 (6). 314-320.
53. Nielsen AA, Nielsen JN, Gronbaek H., et al. Impact of enteral supplements enriched with omega-3 fatty acids and/or omega-6 fatty acids, arginine and ribonucleic acid compounds on leptin levels and nutritional status in active Crohn's disease treated with prednisolone. Digestion. 2007 ; 75 (1). 10-16. (Pubitemid 46712747)
54. Oz HS, Ray M., Chen TS, McClain CJ Efficacy of a transforming growth factor β2 containing nutritional support formula in a murine model of inflammatory bowel disease. J Am Coll Nutr. 2004 ; 23 (3). 220-226. (Pubitemid 38746110)
55. Fell JM, Paintin M., Arnaud-Battandier F., et al. Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease. Aliment Pharmacol Ther. 2000 ; 14 (3). 281-289. (Pubitemid 30145315)
56. Ramirez S., Moreau J., Hebuterne X., et al. Tolerance, modalities of regulation and effectiveness of oral nutrition with a specific mixture polymeric in Crohn's disease in the adult [in French]. Nutr Clin Metabol. 2004 ; 18: 551.
57. Dray X., Marteau P. The use of enteral nutrition in the management of Crohn's disease in adults. JPEN J Parenter Enteral Nutr. 2005 ; 29 (4 )(suppl). S166 - S172.
58. Lochs H., Steinhardt HJ, Klaus-Wentz B., et al. Comparison of enteral nutrition and drug treatment in active Crohn's disease: results of the European Cooperative Crohn's Disease Study: IV. Gastroenterology. 1991 ; 101 (4). 881-888.
59. Goh J., O'Morain CA Review article: nutrition and adult inflammatory bowel disease. Aliment Pharmacol Ther. 2003 ; 17 (3). 307-320. (Pubitemid 36259393)
60. Teahon K., Bjarnason I., Pearson M., Levi AJ Ten years' experience with an elemental diet in the management of Crohn's disease. Gut. 1990 ; 31 (10). 1133-1137. (Pubitemid 20343054)
61. Dziechciarz P., Horvath A., Shamir R., Szajewska H. Meta-analysis: enteral nutrition in active Crohn's disease in children. Aliment Pharmacol Ther. 2007 ; 26 (6). 795-806. (Pubitemid 47346708)
62. Griffiths AM, Ohlsson A., Sherman PM, Sutherland LR Meta-analysis of enteral nutrition as a primary treatment of active Crohn's disease. Gastroenterology. 1995 ; 108 (4). 1056-1067.
63. Griffiths AM Enteral nutrition in the management of Crohn's disease. JPEN J Parenter Enteral Nutr. 2005 ; 29 (4 )(suppl). S108 - S117.
64. Targan SR, Hanauer SB, van Deventer SJ, et al. Crohn's Disease cA2 Study Group. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease. N Engl J Med. 1997 ; 337 (15). 1029-1035.
65. Hanauer SB, Feagan BG, Lichtenstein GR, et al. ACCENT I Study Group. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet. 2002 ; 359 (9317). 1541-1549. (Pubitemid 34621118)
66. Lichtenstein GR, Feagan BG, Cohen RD, et al. Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry. Clin Gastroenterol Hepatol. 2006 ; 4 (5). 621-630.
67. Bernstein CN, Shanahan F. Critical appraisal of enteral nutrition as primary therapy in adults with Crohn's disease. Am J Gastroenterol. 1996 ; 91 (10). 2075-2079. (Pubitemid 26338955)
68. Clark M., Colombel JF, Feagan BC, et al. American Gastroenterological Association Consensus Development Conference on the Use of Biologics in the Treatment of Inflammatory Bowel Disease, June 21-23, 2006. Gastroenterology. 2007 ;133(1): 312-339.
69. Colombel JF, Loftus EV Jr, Tremaine WJ, et al. The safety profile of infliximab in patients with Crohn's disease: the Mayo Clinic experience in 500 patients. Gastroenterology. 2004 ; 126 (1). 19-31.